MATRIX METALLOPROTEINASE-2 (MMP-2 ) AND-9 (MMP-9) GENE VARIANTS AND MICROVASCULAR COMPLICATIONS IN TYPE 2 DIABETES PATIENTS
Andjelic Jelic M٭ˡ, Radojkovic D², Nikolic A², Rakicevic Lj², Babic T², Jelic D³, Lalic NM⁴
*Corresponding Author: Marina Andjelic Jelic, Department of Endocrinology, Diabetes and Metabolic Diseases, Clinical Medical Centre Zvezdara, Dimitrija Tucovica 161, 11000 Belgrade, Serbia, Phone +381 64 122 2010 Fax +381 11 3088733, E mail: drmajelic@gmail.com
page: 6

REFERENCES

1. IDF Diabetes Atlas Ninth edition 2019. 2. Callaghan BC, Price RS, Feldman EL. Distal Symmetric Polyneuropathy: A Review. JAMA. 2015; 314: 21722181. 3. Afkarian M, et al. Clinical Manifestations of Kidney Disease among US Adults with Diabetes, 1988- 2014. JAMA. 2016; 316: 602610. 4. Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond). 2015; 2-17. 5. Doria A. Genetics of Diabetes Complications. Curr Diab Rep. 2010; 10(6): 467475. 6. Negase H, Woessnsner JF Jr. Matrix metalloproteinases. J Biol Chem. 1999; 274:21491-21494. 7. Nikolaos P, Kadoglou, Daskalopoulou S, Perrera D, Liapis C. Matrix Metalloproteinases and Diabetic Vascular Complications. Angiology. 2005; 56: 173189. 8. Kowluru RA, Mishra M. Regulation of Matrix Metalloproteinase in the Pathogenesis of Diabetic Retinopathy. Prog Mol Biol Transl Sci. 2017; 148: 67-85. 9. Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. N Engl J Med Overseas Ed. 2012; 366:1227-39. 10. Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012; 35: 556564. 11. Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010; 376: 12436. 12. Diabetes Control and Complications Trial Research Group.The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes. 1995; 44: 968983. 13. Jerneld B, Algvere P. Relationship of duration and onset of diabetes to prevalence of diabetic r.tinopathy. Am. J. Ophtalmol. 1986; 102: 431437. 14. Matthews DR, Stratton IM, Aldington SJ, Holman RR, Kohner EM. Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus UKPDS 69. Arch. Ophthalmol. 2004; 122(11): 16311640. 15. Simó-Servat O, Hernández O, Simó R. Genetics in diabetic retinopathy: Current Concepts and New Insights. Curr Genomics. 2013; 14(5): 289299. 16. Giebel S, Menicucci G, Mc Guire PG, Das A. Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of blood retinal barrier. Lab Invest. 2005; 85: 567-607. 17. Mohammad G, Kowluru RA. Matrix metalloproteinase -2 in the development of diabetic retinopathy and mitochondrial dysfunction. Lab Invest. 2010; 90(9): 1365-1372. 18. Grant MB, Caballero S, Tarnuyyer RW, Bass KE, Ljubinkov AV, Spoerri PE, Galardy RE. Matrix metalloproteinase expression in human retinal microvascular cells. Diabetes. 1998; 47: 1311-7. 19. Salzmann J, Limb GA, Khaw PT, Gregor Z, Webster L, Chignell AH, Charteris D. Matrix metalloproteinase and their natural inhibitors in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophtalmo. 2000; 84: 1091-6. 20. Singh K, Goyal P, Singh M, Deshmukh S, Upadhyay D, Kant S, Agrawal NK, Gupta SK, Singh K. Association of functional SNP-1562C>T in MMP-9 promoter with proliferative diabetic retinopathy in north Indian type 2 diabetes mellitus patients. J Diabetes Complications. 2017; 31(12): 1648-1651. 21. Beranek M, Kolar P, Tschoplova S, Kankova K, Vasku A. Genetic variations and plasma levels of gelatinase A (matrix metalloproteinase-2 ) and gelatinase B (matrix metalloproteinase-9) in proliferative diabetic retinopathy. Molecular Visio. 2008; 14: 1114-1121. 22. Singh R, Kishore L, Kaur N: Diabetic peripheral neuropathy: current perspective and future directions. Pharmacol Res. 2014; 80: 2135. 23. Argoff CE, Cole BE, Fishbain DA, et al. Diabetic peripheral neuropathic pain: clinical and quality-oflife issues. Mayo Clin Proc. 2006; 81(4): S311. 24. Jann S, Bramerio MA, Beretta S, Koch S, Defanti CA, et al. Diagnostic value of sural nerve matrix metalloproteinase-9 in diabetic patients with CIPD. Neurology. 2003; 61: 1607-1610. 25. Kuhad A, Singh P, Chopra K. Matrix metalloproteinases: potential therapeutic target for diabetic neuropathic pain. Expert Opin Ther Targets. 2015; 19(2): 177-85. 26. Deng X, Ma P, Wu M, Liao H, Sung XJ. Role of matrix metalloproteinases in myelin abnormalities and mechanical allodynia in rodents with diabetic neuropathy. Aging Dis. 2021; 12(7): 1808-1820. 27. Singh K, Agrawal NK, Gupta SK, Singh K. A functional single nucleotide polymorphism -1562C>T in the matrix metalloproteinase-9 promoter is associated with type 2 diabetes and diabetic foot ulcers. Int J Low Extrem Wounds. 2013; 12(3): 199-204. 28. Tuttle KR, Bakris GL, Bilous RW, et al. Diabetic kidney disease: a report from an ADA Consensus Conference. Diabetes care. 2014; 37: 2864-2883. 29. United States Renal Data System. Annual Data Report: Epidemiology of Kidney Disease in the United States. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2016. 30. Maeda S, Haeda M, Guo B, et al. Dinucleotide repeat polymorphism of matrix metalloproteinase-9 gene is associated with diabetic nephropathy. Kidney Int. 2001; 60: 1428-1434. 31. Shalaby, K., Bahriz, R., Mahsoub, N. et al. Matrix metalloproteinase-9 gene polymorphism (-1562 C/T) and its correlation with diabetic nephropathy. Egypt J Intern Med. 2021; 33: 7. 32. Feng S, Ye G, Bai S, Wei H, Liao X, Li L. Matrix Metalloproteinase-9 -1562C/T Gene Polymorphism Is Associated with Diabetic Nephropathy. Biomed Res Int. 2016; 1627143. 33. Gantala SR, Kondapalli MS, Kummari R, Padala C, Tupurani MA, et al. Collagenase-1 (-1607 1G/2G), Gelatinase-A (-1306 C/T), Stromelysin-1 (-1171 5A/6A) functional promoter polymorphisms in risk prediction of type 2 diabetic nephropathy. Gene. 2018; 673: 22-31. 34. Behrforouz A, Dastgheib SA, Abbasi H, Karimi- Zarrchi M, Javaheri A, Hadadan A, Tabatabaei RS, Meibodi B, Neamatzadeh H. Association of MMP- 2, MMP-3 and MMP-9 polymorhisms with susceptibility to recurrent pregnancy loss. Fetal Pediatr Pathol. 2021; 40(5): 378-386. 35. Sarray S, Dallel M, Lamine LBj Jairajpuri D, Sellami N et al. Association of matrix metalloproteinase-2 gene polymorphism with susceptibility to type 2 diabetesː A case control study. J Diabetes Complications. 2021; 35(6): 107908.



Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006